GUTS

Fractyl Health, Inc.

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$0.81

Price (1 Year)

$27.24 $0.81

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %19 / %30
Non-compliant assets / Total market cap %22.6 / %30
Non-compliant revenue / Total income %100 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. It develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans.

Website

Analysis (Turkish): GUTS Hissesi Caiz mi, Helal mi? Fractyl Health, Inc. Katılım Analizi